Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL26675303

COc1ccccc1C(=O)n1nc(N)c2ccc(C3CC3)nc21.O=C(O)C(F)(F)F

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ F2 P00734 6/20 0.41
▸ MAPT P10636 6/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ POLB P06746 3/20 0.41
▸ F12 P00748 2/20 0.39
▸ TTR P02766 1/20 0.39
▸ NTSR1 P30989 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ KLKB1 P03952 1/20 0.38
▸ KLK1 P06870 1/20 0.38
▸ HCRTR2 O43614 1/20 0.37
▸ MGAM O43451 1/20 0.37
▸ AMY1A P0DUB6 1/20 0.37
▸ GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26675432 0.93 ALOX15 (0.48) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL30600508 0.89 ALOX15 (0.47) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL26675308 0.89 ALOX15 (0.47) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL26675452 0.84 ALOX15 (0.44) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL29767948 0.84 ALOX15 (0.44) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL30600523 0.84 MAPT (0.49) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL26675424 0.84 MAPT (0.49) ALOX15HSD17B10MAPTSMN1; SMN2HTT
SCHEMBL30675610 0.83 ALOX15 (0.46) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL29767956 0.83 ALOX15 (0.46) ALOX15HSD17B10F2MAPTSMN1; SMN2
SCHEMBL26675362 0.83 ALOX15 (0.46) ALOX15HSD17B10F2MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US claimed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN claimed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 — — US disclosed
CN-116867782-A Pyrazole amide derivative 豪夫迈·罗氏有限公司 2023-10-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 ALOX15 3863/4885HSD17B10 2897/4885F2 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback